Pulse Biosciences, Inc (PLSE) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Pulse Biosciences (PLSE) Q1 2026: NSPFA Clinical Milestones Tighten Pivotal Trial Timeline
July 26, 2026
-
Pulse Biosciences (PLSE) Q4 2025: 96% One-Year Success in AFib Study Sets Stage for 2026 Clinical Ramp
February 23, 2026
-
Pulse Biosciences (PLSE) Q3 2025: Initial Revenue at $86K as Nanosecond PFA Adoption Grows
November 06, 2025
-
Pulse Biosciences (PLSE) Q2 2025: R&D Spend to Rise with Two IDE Trials and Commercial Launch
August 12, 2025
-
Pulse Biosciences (PLSE) Q1 2025: Cash Jumps to $119M as NSPFA Clinical Momentum Builds
July 05, 2025